SAM Credit – Live Events
Collapse SAMs and CME/CMLE Credit for the AMP 2018 Annual Meeting and Expo

The AMP 2018 Annual Meeting and Expo will have SAM credits available for select sessions.

CLICK HERE to see that talks/sessions that include SAM. This information is also available on the mobile online meeting app.

 

Purchase this if you wish to claim SAMs alone or a combination of SAMs and CME/CMLE for the AMP 2018 Annual Meeting and Expo.

After the annual meeting, you will be given access to the SAM online exam and online evaluation.

 

IMPORTANT DEADLINES

  • Deadline to purchase SAM is December 15, 2018
  • Deadline to complete SAM tests is December 31, 2018 11:59pm (23:50) Eastern Time. 

How to purchase:

  1. Click on "Add to Basket" on the menu to the left.
  2. Login with your AMP Member/Customer Username and Password.
  3. Proceed to "Checkout" along with providing payment information and submit order.

How to Claim SAMs: (Instructions will be posted here after the Annual Meeting and emailed to purchasers within 1 week of purchase)?


SAM Credit

This activity ("Association for Molecular Pathology 2018 Annual Meeting and Expo") is approved by the American Board of Pathology for a maximum of 13.5 credit hours. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online exam (answering at least 80% of the questions correctly).

 

CME/CMLE Credit
This activity ("Association for Molecular Pathology 2018 Annual Meeting and Expo") was planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Society for Clinical Pathology (ASCP) and the Association for Molecular Pathology (AMP). The ASCP is accredited by the ACCME to provide continuing medical education for physicians.

The ASCP designates this live educational activity for a maximum of 20.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The ASCP designates this activity for a maximum of 20.75 Continuing Medical Laboratory Education (CMLE) credit hours. CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity.

 

Note: Join the AMP Family to purchase this for a discount!

 

Formats Available: SAM Credit for AM18
Original Course Date: November 01, 2018
MORE INFOMORE INFO SAMs and CME/CMLE Credit for the AMP 2018 Annual Meeting and Expo
Collapse Tumor Mutational Burden: Result Reporting and Application to Improve Patient Care (+SAM)

  This product includes the webinar and SAM credit


Speaker:

      Ahmet Zehir, PhD     

Moderator:

Jonathan Nowak, MD, PhD

Description: As tumor mutational burden (TMB) is gaining traction as a predictive biomarker for immunotherapy, the challenge of reporting TMB back to the treating oncologists and patients in an informative way still exists. In this webinar, we will discuss strategies of implementing TMB in the clinical laboratory, how different TMB values reported from various assays compare to each other, and how to communicate the results in a clear way.

Duration: 1 hr

Level of Instruction: Basic

Last day to purchase course and claim credit: September 26, 2021

Maximum SAM credit available: 1.0

This webinar is part 3 of a three-part series exploring how measuring tumor mutational burden can improve patient care. If you'd like more information about the series go here.

This program has been supported through an educational grant from Bristol-Myers Squibb.


How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

This course is approved by the American Board of Pathology for 1.0 SAM credits.Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

SAM questions edited by: Honey Reddi, PhD


You may also be interested in:

Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Formats Available: Zehir (+SAM)
Original Course Date: September 26, 2018

Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO Tumor Mutational Burden: Result Reporting and Application to Improve Patient Care (+SAM)
    SAM Credit – On Demand
    Collapse 2016 World Health Organization (WHO) Updates in Hematologic Malignancies Bundle (+AMP Certificate  + SAM)

    This product includes SAM as well as the 5 hours of lecture content, the lecture slides, key reference sheet, a post-course exam, and an AMP Certificate of Completion. 


    Description:

    Since the publication of the World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues in 2008, there have been significant advances in our knowledge of the biology and genetics of hematopoietic malignancies resulting in improved diagnostic and prognostic criteria, disease classification and therapeutic strategies. The 2016 WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues incorporates these advances with revisions to current entities and addition of provisional entities. This AMP certificate program will cover the major changes made in the 2016 WHO revision. Participants will learn from experts in the field covering the following topics: B lymphoid neoplasms, Peripheral T cell lymphomas, Acute Leukemias, Myeloproliferative Neoplasms, Myelodysplastic syndromes and Myelodysplastic/myeloproliferative neoplasms. An update on the clinicopathologic features and classification of hematologic malignancies will be presented providing participants with skills and knowledge to accurately diagnose and subclassify hematologic malignances according to the revised 2016 WHO criteria.

    Target Audience: Practicing pathologists, oncologists, medical trainees and other healthcare professionals in the U.S. and abroad.

    This certificate program was planned and coordinated by the Content Directors:

    • Jennifer Dunlap, MD, Oregon Health & Science University, Portland, OR
    • Mark D, Ewalt, MD, University of Colorado, Denver, CO

    and supported by the Training & Education Committee (Cecilia C.S. Yeung, MD, Chair) 

    Duration: 5 hours

    Certificate Program Topics (for details about each topic, click on the “Topics” tab at the top of the page)

    • B-Lymphoid Neoplasms (Eric D. Hsi, MD)
    • Nodal Peripheral T-cell Lymphomas (Stefano A. Pileri, MD)
    • Acute Leukemias (Daniel A. Arber, MD)
    • Myeloidproliferative Neoplasms (Tracy I. George, MD)
    • MDS and MDS/MPN (Robert Hasserjian, MD)

     

    Last day to purchase course and claim credit: January 18, 2021

    Maximum SAM credit available: 5.0

    The content for this certificate program was made in collaboration with Association for Molecular Pathology (AMP) and Society for Hematopathology (SH)


    How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    This course is approved by the American Board of Pathology for 5.0 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).


    You might also be interested in:

     

    Note: Members of AMP can access this content for a deep discount. Join the AMP Family!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

     

    Formats Available: WHO AMP + SAM
    Original Course Date: May 31, 2018

    Approved Credit:
  • ABP: 5.00 hours Self-Assessment Module
  • AMP: 5.00 hours Molecular Pathology Content

  • MORE INFOMORE INFO 2016 World Health Organization (WHO) Updates in Hematologic Malignancies Bundle (+AMP Certificate  + SAM)
    Collapse 2017 AMPlicons: A Practical Molecular Toolkit and Case Studies Online Course (+CME/CMLE and SAM)
    Formats Available: AMPlicons 2017
    Original Course Date: November 15, 2017
    On-Demand Release Date: Available Now

    Approved Credit:
  • ABP: 4.50 hours Self-Assessment Module
  • AMA: 4.50 hours Continuing Medical Education
  • ASCP: 4.50 hours CMLE

  • MORE INFOMORE INFO 2017 AMPlicons: A Practical Molecular Toolkit and Case Studies Online Course (+CME/CMLE and SAM)
    Collapse AMP 2017 Annual Meeting Highlights (+SAM)
    Recordings of Selected Presentations from AMP 2017 Annual Meeting

    This collection includes select recordings of the 2017 Annual Meeting presentations and SAM credit for most of these sessions. See the table below for a list of the recordings and SAM eligible sessions in this collection.


    The AMP 2017 Annual Meeting (November 16-18, 2017 in Salt Lake City, UT) showcased an impressive roster of speakers covering a wide range of topics in molecular diagnostics. The theme for the meeting was "Where Molecular Leads Medicine to Best Patient Care" and the presentations highlighted the true clinical utility for molecular diagnostics. In the AMP 2017 Annual Meeting Highlights, catch up on the the most cutting-edge research in molecular pathology in topics ranging from CRISPR technologies, liquid biopsies, and the microbiome, to epigenetic roles in human disease, to new tools for interpreting the cancer genome. Click on the "Topics" tab for a list of the available presentations and click on the titles for more information about each session.

    Duration:  13.25 hrs

    Last day to purchase course and claim credit: November 30, 2019

    Maximum SAM credit available: 11.25

    You can purchase individual talks or purchase all of the AMP 2017 Annual Meeting Highlights for a discount.

    • To purchase the entire series, click the "Add to Cart" button located on the right.
    • To purchase individual talks, click on the "Purchase Individual Topics" button on the right, and select the particular talk(s) that you would like to purchase.

     

    If you have questions, please email AMPeducation@amp.org


    Recordings Available

    SAM Credit

    Award for Excellence Lecture: The Epigenetic Basis of Common Human Disease

    • Andrew P. Feinberg, MD, MPH
    No SAMs available

    Molecular Genetics and Biomarkers of B-cell Leukemias and Lymphomas

    • Precursor B-cell Neoplasms (ALL)
      Charles G. Mullighan, MBBS (Hons), MSc, MD
    • Genetic and Epigenetic Drivers of Diffuse Large B Cell Lymphoma
      Laura Pasqualucci, MD
    1.5

    Discovering the Links: Infectious Agents and Cancer

    • HPV and Head and Neck Cancer
      Joseph A. Califano, MD
    • Blood-based Assessment of EBV DNA as a Tumor Marker
      Jennifer A. Kanakry, MD
    1.5

    The Hunt for Microbes: The Beginning of the End of the Pandemic Era

    • Microbial Anthropology
      Maria G. Dominguez-Bello, PhD, BSc, MSc
    • A Collaborative Effort to End the Pandemic Era: The Global Virome Project
      Jonna Mazet, DVM, MPVM, PhD
    1.5

    Molecular Informatics at Scale for Genomics-based Personalized Cancer Care

    • Molecular Pathology Informatics - Toolsets and Infrastructures for Supporting Clinical Trials
      Mark Routbort, MD, PhD
    • Interpreting the Cancer Genome: Identifying Driver Alterations and Therapeutic Options*
      Nikolaus Schultz, PhD

    *Only Nikolaus Schultz’s talk is eligible for SAM Credit

    0.75*

    High Impact Molecular Diagnostics for Cancer and Inherited Diseases

    • Solid Tumor Genotyping: Technical and Clinical Validation with a Focus on Fusions
      A. John Iafrate, MD, PhD
    • Intersection of Germline and Somatic Cancer Variants and New Areas of Clinical Utility
      Colin C. Pritchard, MD, PhD
    1.5

    Molecular Testing in the Practice of Cardiology

    • Phenotype to Genotype: How Traditional Techniques Pave the Way to Targeted Testing and Individualized Medicine
      Joseph J. Maleszewski, MD
    • From Genes to Genomes: Evolution of Molecular Testing for Inherited Cardiomyopathies
      Birgit Funke, PhD
    1.5

    Mitochondrial Disease: Diagnosis, Treatment and Prevention

    • Overview of Mitochondrial Disease and Nuclear Genetic Causes
      Marni J. Falk, MD
    • Mitochondrial DNA Disease: Etiology, Diagnosis, and Prevention
      Sir Doug Turnbull, MBBS, MD, PhD
    1.5

    Role of Genome Editing in Research and Therapy

    • Genome Editing with CRISPR-Cas Nucleases
      J. Keith Joung, MD, PhD
    • Accelerating Prediction of Tumor Vulnerabilities Using Next-generation Cancer Models
      Jesse S. Boehm, PhD

    1.5

     


    HOW TO CLAIM SAM:

    To earn SAM credit, all learners must watch the webinars, achieve a minimum score of 75-80% on the online quiz, and complete the online survey. To access the quiz and survey click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left.

    Click here for detailed instructions on how to claim SAM.

     

    SAM Credit

    This course is approved by the American Board of Pathology for 11.25 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

     

    Note: Join the AMP Family to purchase this content for a deep discount!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

    Formats Available: Highlights 17 + SAM
    Original Course Date: November 16, 2017
    On-Demand Release Date: Available Now

    Approved Credit:
  • ABP: 11.25 hours Self-Assessment Module

  • MORE INFOMORE INFO AMP 2017 Annual Meeting Highlights (+SAM)
    Collapse AMP 2017 Global Congress Highlights (+SAM)
    Recordings of Selected Presentations from AMP 2017 Global Congress

    This collection includes SAM credit.


    The AMP 2017 Global Congress in Berlin was a multi-disciplinary scientific program showcasing molecular technology with clinical applications in oncology, genetics, and infectious diseases. AMP Education has assembled the “AMP 2017 Global Congress Highlights,” which includes a selection of some of the most highly rated presentations and asked the speakers to record their talks from the meeting. This selection of excellent presentations includes:

    All recordings below are eligible for SAM credit. Test your knowledge of the materials with the SAM quiz and receive the SAM certificate.

    Presentations include (SAM Credit Available):

    Speaker               Title SAM Credit
    Mariangela Russo Cancer Evolution as a Therapeutic Target 0.75
    Somak Roy Somatic Variant Interpretation and Reporting - The Informatics Underpinning in the Light of Recent AMP Guidelines 1.0
    James Versalovic The Human Gastrointestinal Microbiome and Advances in Metagenomic Medicine 1.0
    Avni B. Santani Complexities in the Analysis and Interpretation of NGS Data for Inherited Disorders 1.0

    Last day to purchase course and claim credit: April 5, 2020

    Maximum SAM credit available: 3.75


    You can purchase individual talks (+SAM) or the entire AMP 2017 Global Congress Highlights series (+SAM) for a discount.

    • To purchase the entire series, click the "Add to Cart" button located on the right.
    • To purchase individual talks, click on the "Purchase Individual Topics" button on the right, and select the particular talk(s) that you would like to purchase.

    How to earn credit

    To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 75% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    SAM Credit:

    This course is approved by the American Board of Pathology for a maximum of 2.75 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online exam (answering at least 80% of the questions correctly). To access the quiz, click on the "submit credit" button in your classroom.

     

    If you have questions, please email AMPeducation@amp.org

    Note: Join the AMP Family to purchase this content for a deep discount!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

    Formats Available: AMP 2017 Global Highlights + SAM
    Original Course Date: April 05, 2017
    On-Demand Release Date: Available Now

    Approved Credit:
  • ABP: 3.75 hours Self-Assessment Module

  • MORE INFOMORE INFO AMP 2017 Global Congress Highlights (+SAM)
    Collapse AMP 2017 Molecular Genetic Pathology (MGP) Online Self-Study Review Course (+CME/CMLE and SAM)

    The AMP Molecular Genetic Pathology (MGP) Review Course is an intense update and review of molecular diagnostics that is geared towards individuals preparing for the Molecular Genetic Pathology (MGP) Subspecialty Certification Exam or for those looking for a refresher or an introduction to molecular genetic pathology. Learn directly from recognized experts in molecular pathology, most of whom hold the MGP certification. Go here for more information on the course. 

    This online course includes all the recorded presentations, course materials, case studies, and tests from the live course held on June 1-4, 2017. Learn at your own pace and rewatch lectures as many times as you'd like.

     

    We also offer this course packaged at a discount for multiple trainee users at the same insitution. Click here for more details.

     

    Note - registrants who attended the face-to-face course do not need to register for the online course to access the online materials.


    CME/CMLE credit and SAMs credit are both available with the purchase of this course. Credit will expire on December 31, 2018

    How to claim credit: To earn CE credit, all learners must watch the lectures, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz and the online survey, click "Submit credit" on the course homepage, or click on "My Credit" on the menu to the left.

    AMA PRA Category 1 Credit(s)™

    This activity was planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society for Clinical Pathology (ASCP) and the Association for Molecular Pathology. ASCP is accredited by the ACCME to provide continuing medical education for physicians.

    The ASCP designates this enduring educational activity for a maximum of 22.75 AMA PRA Category 1 Credit(s) TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

    This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 22.75 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the ASCP Board of Certification (BOC) Certification Maintenance Program (CMP).CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity.

    SAMs Credit

    This course is approved by the American Board of Pathology for 18.75 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online exam (answering at least 80% of the questions correctly).

     

    DISCLAIMER: AMP makes no guarantee or assurances that completion of its courses or participation in any educational activity will in any manner ensure a passing score on any certification examination or activity post-test, or achievement of certification status. The AMP Molecular Genetic Pathology review course is an educational program provided by the Association for Molecular Pathology, (AMP) and is not sponsored or endorsed by the American Board of Pathology (ABP) or the American Board of Medical Genetics (ABMG).

     

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

    Formats Available: MGP Review Course - Online Self Study
    Original Course Date: June 08, 2017
    On-Demand Release Date: Available Now

    Approved Credit:
  • AMA: 22.75 hours Continuing Medical Education
  • ASCP: 22.75 hours CMLE
  • ABP: 18.75 hours Self-Assessment Module

  • MORE INFOMORE INFO AMP 2017 Molecular Genetic Pathology (MGP) Online Self-Study Review Course (+CME/CMLE and SAM)
    Collapse AMP/ASCO/CAP Standards and Guidelines of Somatic Variant Interpretation and Reporting (+SAM)

    This product includes the webinar and SAM credit.


    Description:

    In January 2017, a working group comprised of representatives from the Association for Molecular Pathology (AMP), College of American Pathologists (CAP), American Society of Clinical Oncology (ASCO), and American College of Medical Genetics and Genomics (ACMG) published the guidelines for the interpretation and reporting of somatic variants. This subject matter expert panel comprised of investigators with expertise in molecular pathology, medical genetics, and clinical oncology, assessed the current status of NGS-based testing for cancer and established standardized classification, annotation, interpretation, and reporting conventions for sequence variants associated with cancer.

    In this webinar, Dr. Marilyn M. Li summarizes the guideline and provides a number of examples illustrating how to implement the classification system.


    Practice Guideline Available Here

    Speaker: Marilyn M. Li, MD

    Host: Antonia R. Sepulveda, MD, PhD

    Duration: 1 hr

    Level of Instruction: Basic

    Last day to purchase course and claim credit: January 26, 2021

    Maximum SAM credit available: 1.0


    How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    This course is approved by the American Board of Pathology for 1.0 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).


    You may also be interested in:

     

    Note: Join the AMP Family to purchase this content for a deep discount!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

     

    Formats Available: Li Webinar +SAM
    Original Course Date: January 26, 2018

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO AMP/ASCO/CAP Standards and Guidelines of Somatic Variant Interpretation and Reporting (+SAM)
    Collapse Best Practices in NSCLC Small Specimen Collection for Clinicians (+SAM)

      This product includes the webinar and SAM credit


    Speaker

    Eric H. Bernicker, MD

    Moderator

    Christopher R. Gilbert, DO

    Description:

    Targeted therapies for advanced lung cancers continue to expand rapidly. Viewers of this presentation will get an overview of the latest developments in the management of oncogene-addicted lung cancers and the need for close collaboration between medical oncologists and pathologists to make sure that patients receive optimal therapy.

    Duration: 1 hr

    Level of Instruction: Basic

    Last day to purchase course and claim credit: June 20, 2021

    Maximum SAM credit available: 1.0

    Supported by an educational grant from AstraZeneca   


    How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    This course is approved by the American Board of Pathology for 1.0 SAM credits.Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

    SAM questions edited by: Rajyasree Emmadi, MD and Alan Brown, MD


    You may also be interested in:

    Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

    Formats Available: NSCLC2 +SAM
    Original Course Date: June 20, 2018

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO Best Practices in NSCLC Small Specimen Collection for Clinicians (+SAM)
    Collapse Best Practices in NSCLC Small Specimen Management for Laboratory Professionals (+SAM)

      This product includes the webinar and SAM credit


     

    Speaker

    Dara Aisner, MD, PhD

    Moderator

    Sinchita Roy-Chowdhuri, MD, PhD

     

    Description: This session will focus on the approaches to management of small tissue samples in the pathology laboratory. These will include diagnostic approaches minimizing use of immunohistochemistry, best practices for maximizing tissue preservation for ancillary studies, and technical considerations for optimal sample use. Additional practices which can be deployed for further tissue maximization will also be discussed.

    Duration: 1 hr

    Level of Instruction: Basic

    Last day to purchase course and claim credit: August 16, 2021

    Maximum SAM credit available: 1.0

    This webinar is part 3 of a five-part series aimed at breaking down barriers to NSCLC testing and treatment. If you'd like more information about the series go here.

    Supported by an educational grant provided by AstraZeneca


    How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    This course is approved by the American Board of Pathology for 1.0 SAM credits.Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

    SAM questions edited by: Honey Reddi, PhD


    You may also be interested in:

    Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

    Formats Available: Aisner (+SAM)
    Original Course Date: August 16, 2018

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO Best Practices in NSCLC Small Specimen Management for Laboratory Professionals (+SAM)
    Collapse Cell Free DNA Testing for Cancer: Clinical Validation, Implementation and Applications (+SAM)

    This course includes the webinar and SAM credit


    Description:

    This webinar will address current concepts in the realm of cell free DNA testing for cancer, with an emphasis on the role of plasma-based testing in patients with non small cell lung carcinoma. Topics to be covered include: the process for validating and implementing cfDNA testing in the hospital setting, the clinical role for cfDNA testing in cancer patients with an emphasis on EGFR-mutated lung carcinoma, and approaches to next generation sequencing for cfDNA.  Practical issues will be emphasized, including clinical performance characteristics of available assays and specimen handling considerations. Selected studies demonstrating the future potential of cfDNA testing for cancer monitoring will be reviewed.


    Speaker: Lynette M. Sholl, MD

    Host: Anthony Snow, MD

    Duration: 1 hr

    Level of Instruction: Basic

    Last day to purchase course and claim credit: September 25, 2020


    How to Claim Credit

    To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 75% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    SAM Credit

    This course is approved by the American Board of Pathology for 1.0 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

     

    Note: Join the AMP Family to purchase this content for a deep discount!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

    Formats Available: Webinar + SAM
    Original Course Date: September 25, 2017

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO Cell Free DNA Testing for Cancer: Clinical Validation, Implementation and Applications (+SAM)
    Collapse Dealing with Highly Homologous Genes in the Context of Medical Sequencing (+ SAM )

    This course includes the webinar and SAM credit


    Description:

    Next-generation sequencing (NGS) is used to interrogate large sets of genes in a diagnostic setting. Regions of high sequence homology are a major challenge and can lead to false-positive and false-negative diagnostic errors. This presentation will provide a perspective on how to deal with medically important genes that have high sequence homology in a diagnostic setting.


    Speaker: Birgit Funke PhD, FACMG

    Host: Avni Santani, PhD

    Duration: 0.75 hr

    Level of Instruction: Intermediate

    Last day to purchase course and claim credit: May 3, 2020


    How to claim credit:

    To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    SAM Credit

    This course is approved by the American Board of Pathology for 0.75 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online quiz (answering at least 80% of the questions correctly). To access the quiz, click on the "submit credit" button in your course or go to "my credit" on the menu to the right and click on "submit credit" for the appropriate course.

     

    Note: Join the AMP Family to purchase this content for a deep discount!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

    Formats Available: Streaming
    Original Course Date: May 03, 2017

    Approved Credit:
  • ABP: 0.75 hours Self-Assessment Module

  • MORE INFOMORE INFO Dealing with Highly Homologous Genes in the Context of Medical Sequencing (+ SAM )
    Collapse Liquid Biopsies - Promises and Pitfalls (+SAM)

      This product includes the webinar and SAM credit


    Speaker

    Lynette M. Sholl, MD

    Moderator

    Christina Lockwood, PhD

    Description: This session will focus on the principles of cell free DNA biology and approaches to detecting genomic alterations in circulating tumor DNA relevant to the diagnosis and management of solid tumor patients. Areas of controversy, as well as technical developments that may expand the use of liquid biopsy in clinical medicine, will be addressed. 

    Duration: 1 hr

    Level of Instruction: Basic

    Last day to purchase course and claim credit: October 9, 2021

    Maximum SAM credit available: 1.0

    This webinar is part 4 of a five-part series aimed at breaking down barriers to NSCLC testing and treatment. If you'd like more information about the series go here.

    Supported by an educational grant provided by AstraZeneca


    How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    This course is approved by the American Board of Pathology for 1.0 SAM credits.Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

    SAM questions edited by: Rajyasree Emmadi, MD


    You may also be interested in:

    Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP

    Formats Available: Sholl (+SAM)
    Original Course Date: October 09, 2018

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO Liquid Biopsies - Promises and Pitfalls (+SAM)
    Collapse Molecular Biomarkers for the Evaluation of Colorectal Cancer (+ SAM )

    This course includes the webinar and SAM credit


    Description:

    In this webinar, Antonia Sepulveda provides an overview of the American Society of Clinical Pathology (ASCP), College of American Pathologists (CAP), Association for Molecular Pathology (AMP), and American Society of Clinical Oncology (ASCO)'s evidence-based practice guideline on molecular marker testing for patients with colorectal carcinoma that identifies opportunities for improving patient outcomes.

     

    The guideline addresses a wide range of molecular markers appropriate for testing in patients with early and advanced colorectal cancer which aids in establishing standard molecular marker testing to help guide targeted therapy decisions and advance personalized care for colorectal cancer patients.


    Practice Guideline Available Here

    Speaker: Antonia R. Sepulveda MD, PhD

    Host: Anna Yemelyanova

    Duration: 1.0 hr

    Level of Instruction: Basic

    Last day to purchase course and claim credit: March 31, 2020


    How to earn credit:

    To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 75% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    SAMs Credit

    This course is approved by the American Board of Pathology for 1.0 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online quiz (answering at least 75% of the questions correctly).

     

    Note: Join the AMP Family to purchase this content for a deep discount!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

    Formats Available: Streaming
    Original Course Date: March 31, 2017

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO Molecular Biomarkers for the Evaluation of Colorectal Cancer (+ SAM )
    Collapse Molecular Testing Guideline for Selection of Lung Cancer Patients - Revision (+SAM)

    This product includes the webinar and SAM credit


    Speaker:

    Neal Lindeman, MD

    Moderator:

    Anna Yemelyanova, MD


    The advent of targeted therapies based on predictive biomarkers has dramatically altered the role of the molecular pathologist in lung cancer patient care. This webinar reviews the new recommendations published in the revised 2018 CAP/IASLC/AMP lung cancer predictive biomarker guidelines (Lindeman et al.J Mol Diagn, 2018). This webinar, reviewing the evidence and logic behind the new recommendations, is designed for molecular pathologists, pathologists, oncologists, clinicians, trainees, and multidisciplinary tumor boards to help improve NSCLC patient care. Topics to be covered include recommendations regarding new predictive biomarkers; recommendations for testing for EGFR and ALK TKI resistance; and recommendations regarding new testing methodologies including the use of multiplexed genetic sequencing panels (e.g., NGS testing) to identify other treatment options beyond EGFRALK, and ROS1 as well as cell-free circulating DNA testing for EGFR resistance mutations. The revised 2018 CAP/IASLC/AMP lung cancer predictive biomarker guidelines will impact the daily practice of molecular pathologists and clinicians in the care of nearly 150,000 eligible lung cancer patients each year, regardless of whether in a community practice, a large reference lab, or an academic setting, and regardless of their level of expertise or experience.


    Practice Guideline Available Here

    Duration: 1 hr

    Level of Instruction: Basic

    Last day to purchase course and claim credit: May 29, 2021

    Maximum SAM credit available: 1.0

    Supported by an educational grant from AstraZeneca   


    How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    This course is approved by the American Board of Pathology for 1.0 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

    SAM questions edited by: Catherine Cottrell, PhD


    You may also be interested in:

    Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

     

    Formats Available: Lindeman (+SAM)
    Original Course Date: May 29, 2018

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO Molecular Testing Guideline for Selection of Lung Cancer Patients - Revision (+SAM)
    Collapse Mutational Pattern Recognition in Chronic Myeloid Neoplasms (CMNs) (+SAM)

    This product includes the webinar and SAM credit


    Description:

    This presentation summarizes the findings of the Association for Molecular Pathology Chronic Myeloid Neoplasm Working Group. Chronic myeloid neoplasms (CMNs) are defined as a complex group of hematopoietic disorders, encompassing myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPNs), the overlap entities (MDS/MPNs), and systemic mastocytosis. The goal of this group was to distill the vast amounts of literature on the mutational profiles of the CMNs into high impact information that would aid molecular pathologists in the development of next generation sequencing (NGS) myeloid panels. This work identifies 34 genes as the minimum recommended testing list and provides information on the frequency of these genes in the various CMNs as well as their prognostic and therapeutic import. In addition, the findings highlight the recurrent patterns of mutational clonal evolution in these patients, uncovering critical insight into the biology of these neoplasms.


    Practice Guideline Available Here

    Speaker: Annette S. Kim, MD, PhD

    Moderator: Todd W. Kelley, MD

    Duration: 1 hr

    Level of Instruction: Intermediate

    Last day to purchase course and claim credit: July 19, 2021

    Maxiumum SAM credit available: 1.0


    How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    This course is approved by the American Board of Pathology for 1.0 SAM credits.Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

    SAM questions edited by: Alan Brown, MD and Kristin Karner, MD


    You may also be interested in:

     

    Note: Join the AMP Family to purchase this content for a deep discount!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

    Formats Available: Kim (+SAM)
    Original Course Date: July 19, 2018

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO Mutational Pattern Recognition in Chronic Myeloid Neoplasms (CMNs) (+SAM)
    Collapse Practical Considerations for the Validation of Next-Generation Sequencing-Based Oncology Panels (+SAM)

    This product includes the webinar and SAM credit.


                                                                      

    Speaker:
    Lawrence J. Jennings, MD, PhD


    Moderator: 
    Antonia R. Sepulveda, MD, PhD

     

     

    Description: Validation of NGS-based testing for oncology panels can be challenging given the many steps and wide range of targeted mutations. In this presentation, Dr. Jennings will discuss the recent AMP/CAP guideline recommendations for validation and review practical ways to provide documented evidence with the clinical NGS reports.


    Practice Guideline Available Here

    Duration: 1 hr

    Level of Instruction: Basic

    Last day to purchase course and claim credit: April 25, 2021

    Maximum SAM credit available: 1.0


    How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    This course is approved by the American Board of Pathology for 1.0 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

    SAM questions edited by: Catherine Cottrell, PhD


    You may also be interested in:

     

    Note: Members of AMP can access this webinar at a deep discount. Join the AMP Family!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

    Formats Available: Jennings Webinar (+SAM)
    Original Course Date: April 25, 2018

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO Practical Considerations for the Validation of Next-Generation Sequencing-Based Oncology Panels (+SAM)
    Collapse Recommendations for Clinical <i>CYP2C19</i> Genotyping Allele Selection (+SAM)

    This product includes the webinar and SAM credit.


    Description:

    In this webinar, Dr. Karen Weck will present the recommendations of The AMP Pharmacogenomics Working Group of the Clinical Practice Committee for inclusion of variants in CYP2C19 genotyping panels. The working group has published consensus, evidence-based recommendations using criteria such as allele function, population frequency, and availability of reference materials. The recommendations include a Tier 1 minimum set of alleles and defining variants that should be included in all clinical CYP2C19 PGx tests, and a Tier 2 list of additional optional alleles that do not currently meet all of the criteria for inclusion in Tier 1. These recommendations are intended to aid clinical laboratory professionals when designing and validating CYP2C19 genotyping assays, promote standardization of testing across different laboratories, and complement existing clinical guidelines for pharmacogenetic testing.


    Practice Guideline Available Here

    Speaker: Karen E. Weck, MD

    Host: Joshua Deignan, PhD

    Duration: 1 hr

    Level of Instruction: Basic

    Last day to purchase course and claim credit: March 21, 2021

    Maxiumum SAM credit available: 1.0


    How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    This course is approved by the American Board of Pathology for 1.0 SAM credits.Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).


    You may also be interested in:

     

    Note: Join the AMP Family to purchase this content for a deep discount!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

    Formats Available: Weck Presentation (+SAM)
    Original Course Date: March 21, 2018

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO Recommendations for Clinical <i>CYP2C19</i> Genotyping Allele Selection (+SAM)
    Collapse Standards and Guidelines for Validating Next Generation Sequencing Bioinformatics Pipelines: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists (+SAM)

    This product includes the webinar and SAM credit


    Description:

    Bioinformatics pipelines are integral components of next-generation sequencing (NGS) assays. Until recently, a lack of guidelines caused significant variability in how pipelines were validated in the molecular genetics and pathology community. To address this important issue, Association for Molecular Pathology (AMP) with liaison representation from the College of American Pathologists (CAP), and the American Medical Informatics Association (AMIA) released Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines in January 2018. In this webinar, Dr. Somak Roy and Dr. Alexis Carter will highlight some of the important recommendations.


    Practice Guideline Available Here

    Speakers: Somak Roy, MD and Alexis B. Carter, MD

    Moderator: Justin Zook, PhD

    Duration: 1 hr

    Level of Instruction: Basic

    Last day to purchase course and claim credit: April 20, 2021

    Maximum SAM credit available: 1.0


    How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    This course is approved by the American Board of Pathology for 1.0 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

    SAM questions edited by: Midhat Farooqi, MD, PhD


    You may also be interested in:

     

    Note: Join the AMP Family to purchase this content for a deep discount!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

    Formats Available: Roy and Carter Presentation (+SAM)
    Original Course Date: April 20, 2018

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO Standards and Guidelines for Validating Next Generation Sequencing Bioinformatics Pipelines: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists (+SAM)
    Collapse Tumor Mutational Burden: Best Practices to Address Clinical and Technical Challenges (+SAM)

      This product includes the webinar and SAM credit


    Speaker:

    Jonathan Nowak, MD, PhD 

    Moderator:

    Jeremy Segal, MD, PhD

     

    Description: This webinar will cover the methodology for calculating tumor mutational burden (TMB) and will review technical considerations that can impact TMB calculation. The utility of detecting the underlying mutational processes that determine a tumor's mutational burden will also be discussed. The course will cover an overview of immunotherapy drugs, targets, and tumor types for which TMB has been used as a biomarker.

    Duration: 1 hr

    Level of Instruction: Basic

    Last day to purchase course and claim credit: August 28, 2021

    Maximum SAM credit available: 1.0

    This webinar is part 2 of a three-part series exploring how measuring tumor mutational burden can improve patient care. If you'd like more information about the series go here.

    This program has been supported through an educational grant from Bristol-Myers Squibb.


    How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    This course is approved by the American Board of Pathology for 1.0 SAM credits.Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

    SAM questions edited by: Alan Brown, MD


    You may also be interested in:

    Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

    Formats Available: Nowak (+SAM)
    Original Course Date: August 28, 2018

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO Tumor Mutational Burden: Best Practices to Address Clinical and Technical Challenges (+SAM)
    Collapse Tumor Mutational Burden: Clinical and Diagnostic Utilization in Oncology (+SAM)

    This product includes the webinar and SAM credit


    Speaker:

    Lauren Ritterhouse, MD, PhD

    Moderator:

    Susan Hsiao, MD

    Description:  This webinar will cover the background and rationale for the use of tumor mutational burden (TMB) as a biomarker for immunotherapy in oncology. The various biomarkers that have been evaluated for immunotherapy will be explored and a discussion of TMB’s role and use in oncology will be made. The course will cover an overview of immunotherapy drugs, targets, and tumor types for which TMB has been used as a biomarker.

    Duration: 1 hr

    Level of Instruction: Basic

    Last day to purchase course and claim credit: June 27, 2021

    Maximum SAM credit available: 1.0

    This webinar is part 1 of a three-part series exploring how measuring tumor mutational burden can improve patient care. If you'd like more information about the series go here

    This program has been supported through an educational grant from Bristol-Myers Squibb.


    How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    This course is approved by the American Board of Pathology for 1.0 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

    SAM questions edited by: Alan Brown, MD


    You may also be interested in:

     

    Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.


    Formats Available: Ritterhouse (+SAM)
    Original Course Date: June 26, 2018

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO Tumor Mutational Burden: Clinical and Diagnostic Utilization in Oncology (+SAM)
    Collapse WHO 2016 Updates: Acute Leukemias (+SAM)

    This product includes the webinar and SAM credit.


    Description:

    This webinar will review the most recent revision of the World Health Organization (WHO) classification of acute leukemia with a particular focus on acute myeloid leukemia. A summary of changes to the classification of lymphoblastic leukemia/lymphoma and acute leukemias of ambiguous lineage will also be summarized.

    A collaborative educational event presented by Association for Molecular Pathology (AMP) and Society for Hematopathology (SH).


    Speaker: Daniel A. Arber, MD

    Host: Mark D. Ewalt, MD

    Duration: 1 hr

    Level of Instruction: Intermediate

    Last day to purchase course and claim credit: January 22, 2021

    Maxiumum SAM credit available: 1.0


    How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    This course is approved by the American Board of Pathology for 1.0 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).


    You may also be interested in:

     

    Note: Join the AMP Family to purchase this content for a deep discount!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

     

    Formats Available: Arber Presentation (+SAM)
    Original Course Date: January 22, 2018

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO WHO 2016 Updates: Acute Leukemias (+SAM)
    Collapse WHO 2016 Updates: B-Lymphoid Neoplasms (and how practice is changing) (+SAM)

    This product includes the webinar and SAM credit.


    Description:

    In this presentation, Dr. Hsi will review important changes in the recently published update to the 2016 WHO classification of B-cell neoplasms. Topics include monoclonal B-cell lymphocytosis, in situ follicular neoplasia, pediatric type follicular lymphoma, and provisional entities such as large B-cell lymphoma with IRF rearrangement and EBV+ mucocutaneous ulcer. The appropriate molecular characterization of diffuse large B-cell lymphomas and high grade B-cell lymphomas will also be discussed.

    A collaborative educational event presented by Association for Molecular Pathology (AMP) and Society for Hematopathology (SH).


    Speaker: Eric D. Hsi, MD

    Host: Mark D. Ewalt, MD

    Duration: 1 hr

    Level of Instruction: Basic

    Last day to purchase course and claim credit: February 2, 2021

    Maximum SAM credit available: 1.0


    How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    This course is approved by the American Board of Pathology for 1.0 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).


    Note: Join the AMP Family to purchase this content for a deep discount!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

    Formats Available: Hsi Presentation (+SAM)
    Original Course Date: February 02, 2018

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO WHO 2016 Updates: B-Lymphoid Neoplasms (and how practice is changing) (+SAM)
    Collapse WHO 2016 Updates: Myeloproliferative Neoplasms (+SAM)

    This course includes the webinar and SAM credit


    In this webinar, Dr. Tracy George will discuss updates in the classification of myeloproliferative neoplasms, also including eosinophilic neoplasms with recurring mutations, and mastocytosis. This includes new criteria for accelerated phase (response-to-TKI criteria) in chronic myeloid leukemia, WHO 2016 criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis, as well as eosinophilic neoplasms with and without recurring mutations. Updates in the diagnosis of mastocytosis, now its own chapter again in the WHO 2016 classification, will also be explained.

    A collaborative educational event presented by Association for Molecular Pathology (AMP) and Society for Hematopathology (SH).


    Speaker: Tracy I. George, MD

    Host: Mark D. Ewalt, MD

    Duration: 1 hr

    Level of Instruction: Basic

    Last day to purchase course and claim credit: March 1, 2021

    Maximum SAM credit available: 1.0


    How to Claim Credit

    To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 75% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    SAM Credit

    This course is approved by the American Board of Pathology for 1.0 SAM credits.Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).


    You might also be interested in:

     

    Note: Join the AMP Family to purchase this content for a deep discount!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

     

     

    Formats Available: George Presentation (+Sam)
    Original Course Date: March 01, 2018

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO WHO 2016 Updates: Myeloproliferative Neoplasms (+SAM)
    Collapse WHO 2016 Updates: Nodal Peripheral T-cell Lymphomas (+SAM)

    This product includes the webinar and SAM credit.


    Description:

    Following a brief overview on the difficulties encountered in the definition of the epidemiology, classification, diagnosis, prognosis, and therapy of peripheral T/NK-cell lymphomas, nodal peripheral T-cell lymphomas (PTCLs) will be discussed in detail. These neoplasms account for more than 60% of tumours stemming from peripheral T-lymphocytes. In the Revised WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, they correspond to 4 entities: PTCL, not otherwise specified (NOS), PTCLs related to follicular helper T-lymphocytes (FTH), ALK+ anaplastic large cell lymphoma (ALCL), and ALK- ALCL. Tumour related to TFH cells represent a new category, including angioimmunoblastic T-cell lymphoma (AITL), follicular T-cell lymphoma and neoplasms lacking the morphologic characteristics of the previous two subtypes but also stemming from TFH-elements. The latter group was in the past included among PTCLs/NOS. ALK- ALCL was promoted from provisional to accepted entity because of emerging molecular evidences. In addition, the new provisional category of breast implant-associated ALCL was included. Most of the changes introduced in the Revised WHO Classification by comparison with the 2008 fourth edition are due to the extensive application of molecular techniques, including gene expression profiling and next generation sequencing. All the changes will be highlighted and discussed.

    A collaborative educational event presented by Association for Molecular Pathology (AMP) and Society for Hematopathology (SH).


    Speaker: Stefano A. Pileri, MD

    Host: Jennifer Dunlap, MD

    Duration: 1 hr

    Level of Instruction: Intermediate

    Last day to purchase course and claim credit: January 18, 2021

    Maximum SAM credit available: 1.0


    How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    This course is approved by the American Board of Pathology for 1.0 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).


    You may also be interested in:

     

    Note: Join the AMP Family to purchase this content for a deep discount!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

    Formats Available: Pileri Presentation (+SAM)
    Original Course Date: January 18, 2018

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO WHO 2016 Updates: Nodal Peripheral T-cell Lymphomas (+SAM)
    Collapse WHO Update 2016: Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms (+SAM)

    This product includes the webinar and SAM credit.


    Description:

    This webinar reviews the updated diagnostic criteria of myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms according to the recently revised WHO Classification, with emphasis on significant changes from the prior (2008) WHO Classification. New and revised entities within this group of diseases will be presented and the appropriate testing required to correctly diagnose these neoplasms will be discussed.


    Speaker: Robert P. Hasserjian, MD

    Host: Jennifer Dunlap, MD

    Duration: 1 hr

    Level of Instruction: Basic

    Last day to purchase course and claim credit: February 15, 2021

    Maximum CME/CMLE credit available: 1.0


    How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

    This course is approved by the American Board of Pathology for 1.0 SAM credits.Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).


    You may also be interested in:

    Note: Join the AMP Family to purchase this content for a deep discount!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

    Formats Available: Hasserjian Presentatin (+SAM)
    Original Course Date: February 15, 2018

    Approved Credit:
  • ABP: 1 hour Self-Assessment Module

  • MORE INFOMORE INFO WHO Update 2016: Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms (+SAM)